Skip to content

Medical-device intelligence

PRE: Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers

FDA product code PRE: Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PRE
FDA device name
Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers
Device class
2
Regulation number
866.3215
Medical specialty
Microbiology
Review panel
MI

FDA definition

A quantitative gene expression assay using reverse transcription polymerase chain reaction to quantify the relative expression levels of host response genes isolated from whole blood.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Feb 17, 2017 to Jan 10, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
PRE · Rt-Qpcr Assay For Mrna Transcript Immune Biomarkers40

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

4 matching records
Device / recordCompany in FDA recordSourceSource date
TriVerityK241676 · PREInflammatix, Inc.510(k)Jan 10, 2025FDA decision date
SeptiCyte RAPIDK232095 · PREImmunexpress, Inc.510(k)Dec 15, 2023FDA decision date
SeptiCyte RAPIDK203748 · PREImmunexpress, Inc.510(k)Nov 29, 2021FDA decision date
SeptiCyte LABK163260 · PREImmunexpress, Inc.510(k)Feb 17, 2017FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗